The ROAM Research Study Therapy (LTOT) Version (NCT06810323)
The Respiratory Oxygen Adherence Monitor System for COPD With Long Term Oxygen Therapy
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this research is to test a device being developed that can see how patients use oxygen therapy over a long period of time. This study will focus on developing a new display part called ROAM module which will be attached to your oxygen source. The display will provide easily-accessible information that can show how you interact with your supplies and the oxygen machine automatically without connecting the oxygen source to the internet or other devices.
Who can join: Review the eligibility criteria below.
Location: University of Virginia — Charlottesville, Virginia
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- University of Virginia — Charlottesville, Virginia
📞 Contact the Study Coordinator
Phone: (434) 243-6074
Email: RNN3B@VIRGINIA.EDU
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Pulmonary Disease, Chronic Obstructive
- Examining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD) — Birmingham, Alabama
- A Study for GSK3862995B in Healthy Participants and Participants With Chronic Obstructive Pulmonary Disease — Yuma, Arizona
- Evaluating the Clinical Effectiveness of a Patient-specific Silicone Stent — Rochester, Minnesota
- Pragmatic Trial to Enhance Quality Safety, and Patient Experience in COPD — Minneapolis, Minnesota
- Pooled Analysis of Single-arm Studies of Budesonide/Glycopyrronium/Formoterol (BGF) in Routine Care Setting — Mississauga,
- Innate Immunity in Ozone-induced Airway Inflammation in COPD — San Francisco, California
Explore by condition: All Pulmonary Disease, Chronic Obstructive clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.